Molecular evidence for antigen drive in the natural history of mantle cell lymphoma

American Journal of Pathology

Volumn 185, Issue 6, 2015, Pages 1740-1748

  Xochelli, Aliki ^a,b,c   Sutton, Lesley Ann ^c   Agathangelidis, Andreas ^d   Stalika, Evangelia ^a,b   Karypidou, Maria ^a,b   Marantidou, Fotini ^f   Lopez, Alba Navarro ^g   Papadopoulos, Giorgos ^a   Supikova, Jana ^h   Groenen, Patricia ⁱ   Boudjogra, Myriam ^j   Sundstrom, Christer ^c   Ponzoni, Maurilio ^e   Francova, Hana Skuhrova ^h   Anagnostopoulos, Achilles ^b   Pospisilova, Sarka ^h   Papadaki, Theodora ^k   Tzovaras, Dimitris ^a   Ghia, Paolo ^d   Pott, Christiane ^l   Davi, Frederic ^j   Campo, Elias ^g   Rosenquist, Richard ^c   Hadzidimitriou, Anastasia ^a   Belessi, Chrysoula ^f   Stamatopoulos, Kostas ^a,c   more..

^a INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c UPPSALA UNIVERSITY   (Sweden)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f GENERAL HOSPITAL OF NIKEA   (Greece)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY HOSPITAL BRNO   (Czech Republic)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k EVANGELISMOS HOSPITAL   (Greece)

^l UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; MESSENGER RNA; TUMOR ANTIGEN; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE; IMMUNOGLOBULIN VARIABLE REGION;

AMINO ACID SUBSTITUTION; CANCER PATIENT; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SOMATIC HYPERMUTATION; TUMOR MICROENVIRONMENT; B LYMPHOCYTE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; PATHOLOGY;

B-LYMPHOCYTES; CYTIDINE DEAMINASE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, MANTLE-CELL; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84929930247     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.02.006     Document Type: Article

References (42)

1. J.M. Di Noia, and M.S. Neuberger Molecular mechanisms of antibody somatic hypermutation Annu Rev Biochem 76 2007 1 22
2. J. Chaudhuri, U. Basu, A. Zarrin, C. Yan, S. Franco, T. Perlot, B. Vuong, J. Wang, R.T. Phan, A. Datta, J. Manis, and F.W. Alt Evolution of the immunoglobulin heavy chain class switch recombination mechanism Adv Immunol 94 2007 157 214
3. P.E. Patten, C.C. Chu, E. Albesiano, R.N. Damle, X.J. Yan, D. Kim, L. Zhang, A.R. Magli, J. Barrientos, J.E. Kolitz, S.L. Allen, K.R. Rai, S. Roa, P.K. Mongini, T. MacCarthy, M.D. Scharff, and N. Chiorazzi IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions Blood 120 2012 4802 4811
4. J.M. Vose Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management Am J Hematol 87 2012 604 609
5. C. Royo, A. Navarro, G. Clot, I. Salaverria, E. Gine, P. Jares, D. Colomer, A. Wiestner, W.H. Wilson, M.C. Vegliante, V. Fernandez, E.M. Hartmann, N. Trim, W.N. Erber, S.H. Swerdlow, W. Klapper, M.J. Dyer, M. Vargas-Pabon, G. Ott, A. Rosenwald, R. Siebert, A. Lopez-Guillermo, E. Campo, and S. Bea Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease Leukemia 26 2012 1895 1898
6. P. Jares, D. Colomer, and E. Campo Molecular pathogenesis of mantle cell lymphoma J Clin Invest 122 2012 3416 3423
7. F.I. Camacho, P. Algara, A. Rodriguez, E. Ruiz-Ballesteros, M. Mollejo, N. Martinez, J.A. Martinez-Climent, M. Gonzalez, M. Mateo, A. Caleo, M. Sanchez-Beato, J. Menarguez, J. Garcia-Conde, F. Sole, E. Campo, and M.A. Piris Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations Blood 101 2003 4042 4046
8. D. Kienle, A. Krober, T. Katzenberger, G. Ott, E. Leupolt, T.F. Barth, P. Moller, A. Benner, A. Habermann, H.K. Muller-Hermelink, M. Bentz, P. Lichter, H. Dohner, and S. Stilgenbauer VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome Blood 102 2003 3003 3009
9. J. Orchard, R. Garand, Z. Davis, G. Babbage, S. Sahota, E. Matutes, D. Catovsky, P.W. Thomas, H. Avet-Loiseau, and D. Oscier A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease Blood 101 2003 4975 4981
10. M. Schraders, S. Oeschger, P.M. Kluin, K. Hebeda, E. Schuuring, P.J. Groenen, M.L. Hansmann, and J.H. van Krieken Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity Mod Pathol 22 2009 416 425
11. M. Thorselius, S. Walsh, I. Eriksson, U. Thunberg, A. Johnson, C. Backlin, G. Enblad, C. Sundstrom, G. Roos, and R. Rosenquist Somatic hypermutation and V(H) gene usage in mantle cell lymphoma Eur J Haematol 68 2002 217 224
12. S.H. Walsh, M. Thorselius, A. Johnson, O. Soderberg, M. Jerkeman, E. Bjorck, I. Eriksson, U. Thunberg, O. Landgren, M. Ehinger, E. Lofvenberg, K. Wallman, G. Enblad, B. Sander, A. Porwit-MacDonald, M. Dictor, T. Olofsson, C. Sundstrom, G. Roos, and R. Rosenquist Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma Blood 101 2003 4047 4054
13. A. Hadzidimitriou, A. Agathangelidis, N. Darzentas, F. Murray, M.H. Delfau-Larue, L.B. Pedersen, A.N. Lopez, A. Dagklis, P. Rombout, K. Beldjord, A. Kolstad, M.H. Dreyling, A. Anagnostopoulos, A. Tsaftaris, P. Mavragani-Tsipidou, A. Rosenwald, M. Ponzoni, P. Groenen, P. Ghia, B. Sander, T. Papadaki, E. Campo, C. Geisler, R. Rosenquist, F. Davi, C. Pott, and K. Stamatopoulos Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases Blood 118 2011 3088 3095
14. A. Agathangelidis, A. Hadzidimitriou, R. Rosenquist, and K. Stamatopoulos Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells Semin Cancer Biol 21 2011 299 307
15. L.A. Sutton, A. Agathangelidis, C. Belessi, N. Darzentas, F. Davi, P. Ghia, R. Rosenquist, and K. Stamatopoulos Antigen selection in B-cell lymphomas-tracing the evidence Semin Cancer Biol 23 2013 399 409
16. A. Navarro, G. Clot, C. Royo, P. Jares, A. Hadzidimitriou, A. Agathangelidis, V. Bikos, N. Darzentas, T. Papadaki, I. Salaverria, M. Pinyol, X. Puig, J. Palomero, M.C. Vegliante, V. Amador, A. Martinez-Trillos, L. Stefancikova, A. Wiestner, W. Wilson, C. Pott, M.J. Calasanz, N. Trim, W. Erber, B. Sander, G. Ott, A. Rosenwald, D. Colomer, E. Gine, R. Siebert, A. Lopez-Guillermo, K. Stamatopoulos, S. Bea, and E. Campo Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features Cancer Res 72 2012 5307 5316
17. R. Kridel, B. Meissner, S. Rogic, M. Boyle, A. Telenius, B. Woolcock, J. Gunawardana, C. Jenkins, C. Cochrane, S. Ben-Neriah, K. Tan, R.D. Morin, S. Opat, L.H. Sehn, J.M. Connors, M.A. Marra, A.P. Weng, C. Steidl, and R.D. Gascoyne Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma Blood 119 2012 1963 1971
18. M.L. Wang, S. Rule, P. Martin, A. Goy, R. Auer, B.S. Kahl, W. Jurczak, R.H. Advani, J.E. Romaguera, M.E. Williams, J.C. Barrientos, E. Chmielowska, J. Radford, S. Stilgenbauer, M. Dreyling, W.W. Jedrzejczak, P. Johnson, S.E. Spurgeon, L. Li, L. Zhang, K. Newberry, Z. Ou, N. Cheng, B. Fang, J. McGreivy, F. Clow, J.J. Buggy, B.Y. Chang, D.M. Beaupre, L.A. Kunkel, and K.A. Blum Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma N Engl J Med 369 2013 507 516
19. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. ed 4. WHO Classification of Tumours, vol 2. Lyon, France: IARC Press, 2008
20. M.P. Lefranc, V. Giudicelli, C. Ginestoux, J. Jabado-Michaloud, G. Folch, F. Bellahcene, Y. Wu, E. Gemrot, X. Brochet, J. Lane, L. Regnier, F. Ehrenmann, G. Lefranc, and P. Duroux IMGT, the international ImMunoGeneTics information system Nucleic Acids Res 37 2009 D1006 D1012
21. X. Brochet, M.P. Lefranc, and V. Giudicelli IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis Nucleic Acids Res 36 2008 W503 W508
22. L.A. Sutton, E. Kostareli, E. Stalika, A. Tsaftaris, A. Anagnostopoulos, N. Darzentas, R. Rosenquist, and K. Stamatopoulos Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence Mol Med 19 2013 230 236
23. L.A. Sutton, E. Kostareli, A. Hadzidimitriou, N. Darzentas, A. Tsaftaris, A. Anagnostopoulos, R. Rosenquist, and K. Stamatopoulos Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen Blood 114 2009 4460 4468
24. E. Kostareli, L.A. Sutton, A. Hadzidimitriou, N. Darzentas, A. Kouvatsi, A. Tsaftaris, A. Anagnostopoulos, R. Rosenquist, and K. Stamatopoulos Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution Leukemia 24 2010 1317 1324
25. F. Marantidou, A. Dagklis, E. Stalika, P. Korkolopoulou, A. Saetta, A. Anagnostopoulos, N. Laoutaris, K. Stamatopoulos, C. Belessi, Z. Scouras, and E. Patsouris Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia Blood Cells Mol Dis 44 2010 262 267
26. R.N. Damle, T. Wasil, F. Fais, F. Ghiotto, A. Valetto, S.L. Allen, A. Buchbinder, D. Budman, K. Dittmar, J. Kolitz, S.M. Lichtman, P. Schulman, V.P. Vinciguerra, K.R. Rai, M. Ferrarini, and N. Chiorazzi Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 94 1999 1840 1847
27. T.J. Hamblin, Z. Davis, A. Gardiner, D.G. Oscier, and F.K. Stevenson Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia Blood 94 1999 1848 1854
28. F. Murray, N. Darzentas, A. Hadzidimitriou, G. Tobin, M. Boudjogra, C. Scielzo, N. Laoutaris, K. Karlsson, F. Baran-Marzsak, A. Tsaftaris, C. Moreno, A. Anagnostopoulos, F. Caligaris-Cappio, D. Vaur, C. Ouzounis, C. Belessi, P. Ghia, F. Davi, R. Rosenquist, and K. Stamatopoulos Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis Blood 111 2008 1524 1533
29. V. Bikos, N. Darzentas, A. Hadzidimitriou, Z. Davis, S. Hockley, A. Traverse-Glehen, P. Algara, A. Santoro, D. Gonzalez, M. Mollejo, A. Dagklis, F. Gangemi, D.S. Bosler, G. Bourikas, A. Anagnostopoulos, A. Tsaftaris, E. Iannitto, M. Ponzoni, P. Felman, F. Berger, C. Belessi, P. Ghia, T. Papadaki, A. Dogan, M. Degano, E. Matutes, M.A. Piris, D. Oscier, and K. Stamatopoulos Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications Leukemia 26 2012 1638 1646
30. G. Babbage, R. Garand, N. Robillard, N. Zojer, F.K. Stevenson, and S.S. Sahota Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events Blood 103 2004 2795 2798
31. J.E. Guikema, S. Rosati, K. Akkermans, R.J. Bende, C.J. van Noesel, J.H. van Krieken, M.L. Hansmann, E. Schuuring, and P.M. Kluin Quantitative RT-PCR analysis of activation-induced cytidine deaminase expression in tissue samples from mantle cell lymphoma and B-cell chronic lymphocytic leukemia patients Blood 105 2005 2997 2998 discussion 8-9
32. W. Klapper, M. Szczepanowski, K. Heidorn, M. Muschen, S. Liedtke, A. Sotnikova, N.S. Andersen, J. Greeve, and R. Parwaresch Immunoglobulin class-switch recombination occurs in mantle cell lymphomas J Pathol 209 2006 250 257
33. Y. Herishanu, P. Perez-Galan, D. Liu, A. Biancotto, S. Pittaluga, B. Vire, F. Gibellini, N. Njuguna, E. Lee, L. Stennett, N. Raghavachari, P. Liu, J.P. McCoy, M. Raffeld, M. Stetler-Stevenson, C. Yuan, R. Sherry, D.C. Arthur, I. Maric, T. White, G.E. Marti, P. Munson, W.H. Wilson, and A. Wiestner The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia Blood 117 2011 563 574
34. S. Ntoufa, A. Vardi, N. Papakonstantinou, A. Anagnostopoulos, V. Aleporou-Marinou, C. Belessi, P. Ghia, F. Caligaris-Cappio, M. Muzio, and K. Stamatopoulos Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors Mol Med 18 2012 1281 1291
35. R. Bomben, S. Gobessi, M. Dal Bo, S. Volinia, D. Marconi, E. Tissino, D. Benedetti, A. Zucchetto, D. Rossi, G. Gaidano, G. Del Poeta, L. Laurenti, D.G. Efremov, and V. Gattei The miR-17 approximately 92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes Leukemia 26 2012 1584 1593
36. N. Saba, and A. Wiestner Do mantle cell lymphomas have an 'Achilles heel'? Curr Opin Hematol 21 2014 350 357
37. R. Shinkura, S. Ito, N.A. Begum, H. Nagaoka, M. Muramatsu, K. Kinoshita, Y. Sakakibara, H. Hijikata, and T. Honjo Separate domains of AID are required for somatic hypermutation and class-switch recombination Nat Immunol 5 2004 707 712
38. X. Wu, J.R. Darce, S.K. Chang, G.S. Nowakowski, and D.F. Jelinek Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells Blood 112 2008 4675 4682
39. F. van Maldegem, F.A. Scheeren, R. Aarti Jibodh, R.J. Bende, H. Jacobs, and C.J. van Noesel AID splice variants lack deaminase activity Blood 113 2009 1862 1864 author reply 4
40. E. Albesiano, B.T. Messmer, R.N. Damle, S.L. Allen, K.R. Rai, and N. Chiorazzi Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone Blood 102 2003 3333 3339
41. H. McCarthy, W.G. Wierda, L.L. Barron, C.C. Cromwell, J. Wang, K.R. Coombes, R. Rangel, K.S. Elenitoba-Johnson, M.J. Keating, and L.V. Abruzzo High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia Blood 101 2003 4903 4908
42. P. Oppezzo, F. Vuillier, Y. Vasconcelos, G. Dumas, C. Magnac, B. Payelle-Brogard, O. Pritsch, and G. Dighiero Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation Blood 101 2003 4029 4032